Bolt Biotherapeutics, Inc. recorded an outflow of $39.9M in free cash flow in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Bolt Biotherapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
BOLT Free Cash Flow by Fiscal Year
Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
BOLT Free Cash Flow by Quarter
Figures are in USD. Each change compares the quarter with the same quarter a year earlier.
What free cash flow means
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.
More Bolt Biotherapeutics, Inc. financials
Frequently Asked Questions
Bolt Biotherapeutics, Inc. recorded an outflow of $39.9M in free cash flow in fiscal year 2025.
Bolt Biotherapeutics, Inc. (BOLT) reported an outflow of $61.3M in free cash flow in fiscal year 2024 and an outflow of $39.9M in free cash flow in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.
Across the 6 fiscal years this page covers, Bolt Biotherapeutics, Inc. (BOLT) free cash flow went from -$50.6M in fiscal year 2020 to -$39.9M in fiscal year 2025.
Bolt Biotherapeutics, Inc. (BOLT) reported -$3.1M in free cash flow in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Bolt Biotherapeutics, Inc. (BOLT) reported on that line in every period on record.